Abstract
The influence of the renin angiotensin aldosterone system on the structural and electrophysiological remodeling of the failing heart is discussed including changes in cell communication, impulse propagation, and the generation of cardiac arrhythmias. Particular attention was given to the harmful effects of angiotensin II and the beneficial influence of ACE inhibitors, AT1 receptor blockers, and angiotensin [1–7] on cardiac function and cardiac remodeling. Finally, the role of the renin angiotensin aldosterone system on the regulation of cell volume in the failing heart was discussed and evidence was provided that the intracrine RAS plays an important role in the regulation of cell volume. Pathophysiological implications of the change in cell volume are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kirschenbaum, L.A. (2003) Stresses of the failing heart. J Mol Cell Cardiol 35, 1017–1019
Afzal, N., and Dhalla, N.S. (1992) Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol 262, H868–H874
Hill, M.F., and Singal, P.K. (1996) Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148, 291–330
Daniels, M.C., Naya, T., Rundell, V.L., and de Tombe, P.P. (2007) Development of contractile dysfunction in rat heart failure: hierarchy of cellular events. Am J Physiol Reg Integr Com Physiol 293, R284–R292
Cannel, M.B., Corsmann, D.J., and Soeller, C. (2006) T tubules in normal heart run mainly in radial direction while during heart failure are oriented toward the longitudinal axis of the fibers. Effect of changes in action potential spike configuration, junctional SR micro-architecture and altered T tubule structure in human heart failure. J Muscle Res Cell Motil 27, 297–306
Cooper, G. (2006) Increase microtubule density is found in the hypertrophied and failing heart imposing a viscous load on active filaments during contraction.– Cytoskeletal networks and the regulation of cardiac contractility, microtubules, hypertrophy and cardiac dysfunction. Am J Physiol Heart Circ Physiol 29, H1003–H1014
Pacifico, A., and Henry, P.D. (2003) Structural pathways and prevention of heart failure and sudden death. J Cardiovasc Electrophysiol 14, 764–775
Ammoundas, A.A., Wu, R., Juang, G., Marban, E., and Tomaseli, G.F. (2003) Electrical and structural remodeling of the failing ventricle. Pharmacol Ther 92, 213–230
De Mello, W.C. (1999) Cell coupling and impulse propagation in the failing heart. J Cardiovasc Electrophysiol 10, 1409–1430
Severs, N.J. (1994) Pathophysiology of gap junctions in heart disease. J Cardiac Electrophysiol 5, 462–475
Kostin, S. (2007) Zona occludens-1 and connexin 43 expression in the failing human heart. J Cell Mol Med 4, 892–895
De Mello, W.C. (2004) Heart failure: how important is cellular sequestration? The role of the renin angiotensin aldosterone system. J Mol Cell Cardiol 37, 431–438
Emdad, L., Uzzman, M., Takagishi, T., Honjo, H., Uchida, T., and Severs, N.J., et al. (2001) Gap junction remodeling in hypertrophied left ventricles of aorta-banded rats: prevention by angiotensin II type 1 receptor blockade. J Mol Cell Cardiol 33, 219–231
Pimentel, R.C., Yamada, K.A., Kleber, A.G., and Saffitz, J.E. (2002) Autocrine regulation of Cx43 expression by VEGF. Circ Res 90, 671–677
Severs, N.J. (2002) Gap junctions and connexin expression in human heart disease. In: De Mello, W.C., Janse, M., (eds.) Heart Cell Coupling and Impulse Propagation in Health and Disease. Kluwer Academic Publishers, Boston, pp. 321–334
Gupta, R.C., Mishra, S., Rastogi, S., Imai., M,, Habbib, O., and Sabbah, H.N. (2003) Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts. Am J Physiol Heart Circ Physiol 285, H2373–H2381
Dzau, V.J. (1987) Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 59(A), A59–A65
Lindpaintner, K., Jin, M.W., Niedermaier, N., Wilhelm, M.J., and Ganten, D. (1990) Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ Res 67, 564–573
Harada, K., Komuro, I., Hayashi, D., Sugaya, T., Murakami, K., and Yazaki, H. (1998) Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation 97, 315–317
De Mello, W.C. (1996) Renin angiotensin system and cell communication in the failing heart. Hypertension 27, 1267–1272
De Mello, W.C., and Specht, P. (2006) Chronic blockade of angiotensin II AT1 receptors increased cell-to-cell communication, reduced fibrosis and improved impulse propagation in the failing heart. J Renin Angiotensin Aldosterone Syst 7, 201–205
Studer, R., Reinecke, H., and Muller, B., et al. (1994) Increased angiotensin 1 converting enzyme gene expression in the failing human heart. J Clin Invest 94, 301–310
De Mello, W.C. (1994) Is an intracellular renin angiotensin system involved in the control of cell communication in heart? J Cardiovasc Pharmacol 23, 640–646
De Mello, W.C. (2001) Cardiac arrhythmias; the possible role of the renin angiotensin system. J Mol Med 79, 103–108
Satoh Veda, Y, Suematsu, N., and Oyama J., et al. (2003) Beneficial effects of angiotensin converting enzyme inhibitors on sarcoplasmic reticulum function in the failing heart of the Dahl tar. Circ J 67, 705–711
Tokushita, T., Yano, M., Obayashi, M., Noma, T., Mochizuki, M., and Oda, T., et al. (2006) AT1 receptor antagonist restores cardiac rhyanodine receptor function rendering isoproterenol-induced failing heart less susceptible to Ca2+- leak induced by oxidative stress. Circ J 70, 777–786
Hein, L., Stevens, M.E., Barsh, G.S., Pratt, R.E., Kobilka, B.K., and Dzau, V.J. (1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proce Natl Acad Sci USA 94, 6391–6396
Dostal, D.E. (2001) Regulation of cardiac collagen: angiotensin and cross-talk with local growth factors. Hypertension 37, 841–844
Haendeler, J., and Berk, B. (2000) Tyrosine phosphorylation is involved in Ang II-mediated signal transduction. Reg Pept 95, 1–7
Disertori, M., Latini, R., Maggioni, A.P., Delise, P., Di Pasquale, G., Franzosi, M.G., Staszewsky, L., and Tognoni, G. and GISSI-AF Investigators (2006) Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence. J Cardiovasc Med (Hagerstown) 7(1), 29–38
Katz, S.A., Opsahl, J.A., and Lunser, M.M., et al. (1997) Effect of bilateral nephrectmy on active renin, angiotensinogen and renin glycoforms in plasma and myocardium. Hypertension 30, 259–266
Danser, A.H.J., van Katz, J.P., and Admiraal, P.J.J., et al. (1994) Cardiac renin and angiotensins: uptake from plasma versus in situ synthesis. Hypertension 24, 37–48
van den Eijnden, MMED, Saris J.J., and de Bruin, R.J.A., et al. (2001) Prorenin accumulation and activation in human endothelial cells. Importance of mannose-6-phosphate receptors. Arterioscler Thromb Vasc Biol 21, 911–916
Nguyen, G. (2007) The (pro) renin receptor: a new kid in town. Sem Nephrol 27, 519–523
Peters, J., Farrenkopf, R., and Clausmeyer, S., et al. (2002) Functional significance of prorenin internalization in the rat heart. Circ Res 90, 1135–1141
De Mello, W.C. (1995) Influence of intracellular renin on heart cell communication. Hypertension 25, 1172–1177
De Mello, W.C. (2006) Renin increments the inward calcium current in the failing heart. J Hypertens 24, 1181–1186
Schefe, J.H., Menck, M., Reinemunde, J., and Effertz, K., et al. (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99, 1355–1366
Clausmeyer, S., Reinecke, A., and Farrenkopf, R., et al. (2000) Tissue-specific expression of rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology 141, 2963–2970
Griendling, K.K., Soresku, D., and Ushio-Fukai, M. (2000) NAD(P)H oxidase. Role in cardiovascular biology. Circ Res 86, 494–501
Lauersen, J.B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B.A., and Harrison, D.G. (1997) Role of superoxide in angiotensin II-induced but not cathecol-induced hypertension. Circulation 95, 588–593
Diet, F., Pratt, R.E., Berry, G.L., Momose, N., Gibbons, G.H., and Dzau, V.J. (1996) Increased accumulation of tissue ACE in human atherosclerotic coronary disease. Circulation 94, 2756–2767
Hornig, B., Landmesser, U., Kohler, C., Ahlermann, D., and Spiekermann, S., et al. (2001) Comparative effects of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary disease: role of superoxide dismutase. Circulation 103, 799–805
Kamik, A.A., Fields, A.V., and Shannon, R.P. (2007) Diabetic cardiomyopathy. Current Hypertens Rep 9, 467–473
Yamashita, C., Hayahi, T., Mori, T., Tazawa, N., Kwak, C.J., and Nakano, D., et al. (2007) Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein-E-knockout mice. Hypertens Res 30, 1219–1230
Miyajima, K., Minatogushi, S., Ito, Y., Hukunishi, M., and Matsuno, M., et al. (2007) Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension. Hypertens Res 30, 307–313
Donoghue, M., Hsieh, F., and Baronas, E., et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin (1–9). Circ Res 87, E1–E9
Zisman, L.S., Keller, R.S., and Weaver, B., et al. (2003) Increased angiotensin (1-7) forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin converting enzyme homolog, ACE2. Circulation 108, 1707–1712
Ferrario, C., Chappell, M., and Tallant, E.K., et al. (1997) Counterregulatory actions of angiotensin (1-7). Hypertension 30, 535–541
Ferrario, C.M., Trask, A.J., and Jessupt, J, A. (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 289, H2281
Ferreira, A. J., Santos, R.A., and Almeida, A.P. (2001) Angiotensin (1-7); cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38, 665–668
De Mello, W.C. (2004) Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischemia-reperfusion. The role of the sodium pump. J Renin Angiotensin Aldosterone Syst 5, 203–208
De Mello, W.C., Ferrario, C., and Jessupt, J.A. (2007) Beneficial versus harmful effects of angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart. J Renin Angiotensin Aldosterone Syst 8, 74–80
Donoghue, M.,Wakimoto, H., Maguire, C.T., Acton, S. P., and Stagliano, N., et al. (2003) Heart block, ventricular tachycardia and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 35, 1043–1053
Haussinger, D., Reinehr, R., and Schliess, F. (2006) The hepatocyte integrin system and cell volume sensing. Acta Physiol(Oxf) 187, 249–255
Kent, R.L., Hoober, J.B., and Cooper, G. (1989) Local responsiveness of protein synthesis in adult mammalian myocardium: role of cardiac deformation linked to sodium influx. Circ Res 64, 74–85
De Mello, W.C. (2007) Interamerican Soc. of Hypertension Meeting
De Mello, W.C. (2008) Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications to myocardial ischemia. J Renin Angiotensin Aldosterone Syst 9, 112–118
Lang, F. (2007) Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26(5), 613S–623S
Baumgarten, C.M., and Clemo, H.F. (2003) Swelling-activated chloride channels in cardiac physiology and pathophysiology. Prog Biophys Mol Biol 122, 689–702
Delcayre, C., and Swynghedauw, B. (2002) Molecular mechanisms of myocardial remodeling. J Mol Cell Cardiol 34, 1577–1584
Ramires, F.J.A., Mansur, A., and Coelho, O., et al. (2000) Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 85, 207–211
Pitt, B., Zannad, F., and Remme, W.J., et al. for the Randomized Aldactone Evaluation Study Investigators (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 341, 709–717
Pitt, B., Remme, W., and Zannad, F., et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 348, 1309–1321
De Mello, W.C. (2006) Beneficial effect of eplerenone on cardiac remodeling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst 7, 40–46
De Mello, W.C., and Gerena, Y. (2008) Eplererenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system. Reg. Pept 151, 54–60
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
DeMello, W.C. (2009). Structural and Electrophysiological Remodeling of the Failing Heart. In: DeMello, W., Frohlich, E. (eds) Renin Angiotensin System and Cardiovascular Disease. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-60761-186-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-60761-186-8_7
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-185-1
Online ISBN: 978-1-60761-186-8
eBook Packages: MedicineMedicine (R0)